These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8144868)
1. Two cases of Graves' disease with presentation of unilateral diffuse uptake of radioisotopes. Sakata S; Fuwa Y; Goto S; Fukui M; Yuasa H; Takuno H; Sarui H; Matsui I; Ogawa T; Sasano N J Endocrinol Invest; 1993 Dec; 16(11):903-7. PubMed ID: 8144868 [TBL] [Abstract][Full Text] [Related]
2. Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient. Dimai HP; Ramschak-Schwarzer S; Lax S; Lipp RW; Leb G J Endocrinol Invest; 1999 Mar; 22(3):215-9. PubMed ID: 10219891 [TBL] [Abstract][Full Text] [Related]
3. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report. Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843 [TBL] [Abstract][Full Text] [Related]
4. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report. Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094 [TBL] [Abstract][Full Text] [Related]
5. First reported case of unilateral Graves' disease in the left lobe of a bilobar thyroid gland. Chen LC; Green JB Thyroid; 2011 Jun; 21(6):683-6. PubMed ID: 21563918 [TBL] [Abstract][Full Text] [Related]
6. The change in 123I-uptake between 3- and 24-hours is useful in predicting early response to methimazole in patients with Graves' disease. Gemma R; Nakamura H; Mori T; Andoh S; Suzuki Y; Yoshimi T Endocr J; 1996 Feb; 43(1):61-6. PubMed ID: 8732453 [TBL] [Abstract][Full Text] [Related]
7. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease. Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866 [TBL] [Abstract][Full Text] [Related]
8. Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements. Shechner C; Kraiem Z; Zuckerman E; Dickstein G Thyroid; 1992; 2(2):133-5. PubMed ID: 1356055 [TBL] [Abstract][Full Text] [Related]
9. Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels. Wilson R; McKillop JH; Pearson DW; Cuthbert GF; Thomson JA J Nucl Med; 1985 Sep; 26(9):1024-8. PubMed ID: 2863338 [TBL] [Abstract][Full Text] [Related]
10. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease. Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623 [TBL] [Abstract][Full Text] [Related]
11. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis. Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274 [TBL] [Abstract][Full Text] [Related]
12. Immunization with thyroglobulin induces Graves'-like disease in mice. Endo T; Kobayashi T J Endocrinol; 2009 Aug; 202(2):217-22. PubMed ID: 19491147 [TBL] [Abstract][Full Text] [Related]
13. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease. Yunusa GH; Kotze T; Brink A Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115 [TBL] [Abstract][Full Text] [Related]
14. A case of severe cholestatic jaundice associated with Graves' disease. Soysal D; Tatar E; Solmaz S; Kabayeğit O; Tunakan M; Unsal B; Cevik C Turk J Gastroenterol; 2008 Mar; 19(1):77-9. PubMed ID: 18386249 [No Abstract] [Full Text] [Related]
15. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission. Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661 [TBL] [Abstract][Full Text] [Related]
16. Graves' disease with only unilateral involvement; a case report. Bu Bshait MS Int J Surg Case Rep; 2024 Jan; 114():109138. PubMed ID: 38086135 [TBL] [Abstract][Full Text] [Related]
17. [Impact of pretreatment variables on the outcome of standardized 131I therapy with 150 Gray in Graves' disease]. Pfeilschifter J; Elser H; Haufe S; Ziegler R; Georgi P Nuklearmedizin; 1997 Apr; 36(3):81-6. PubMed ID: 9162906 [TBL] [Abstract][Full Text] [Related]
18. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease. Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159 [TBL] [Abstract][Full Text] [Related]
19. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease. Izumi M; Larsen PR J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211 [TBL] [Abstract][Full Text] [Related]
20. Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake. Ikekubo K; Hino M; Ito H; Koh T; Ishihara T; Kurahachi H; Kasagi K; Hidaka A; Mori T Ann Nucl Med; 1990 Jul; 4(2):43-8. PubMed ID: 2171608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]